Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Chief Medical Officer | Josephson Neil | Nov 10, 2022 | Sell | $20.05K | 2,475 |
| Chief Operating Officer | Klompas Neil A | Mar 10, 2022 | Sell | $20.5K | 2,979 |
| Chief Medical Officer | Josephson Neil | Jan 7, 2022 | Buy | $19.98K | 1,400 |
| Chief Medical Officer | Josephson Neil | Jan 7, 2022 | Buy | $51.41K | 3,600 |
| CEO | Tehrani Ali | Jul 16, 2021 | Sell | $1.48M | 41,191 |
| CEO | Tehrani Ali | Jul 15, 2021 | Sell | $136.8K | 3,800 |
| CEO | Tehrani Ali | Jul 12, 2021 | Sell | $457.63K | 12,669 |
| Chief Commercial Officer | Priour James | Apr 13, 2021 | Sell | $26.53K | 950 |
| Chief People Officer | O'Driscoll Kathryn | Mar 15, 2021 | Sell | $27.29K | 786 |
| CEO | Tehrani Ali | Mar 10, 2021 | Sell | $153.52K | 4,392 |
| Chief Medical Officer | HAUSMAN DIANA | Mar 10, 2021 | Sell | $36.63K | 1,048 |
| Chief Scientific Officer | Polverino Anthony J. | Mar 10, 2021 | Sell | $36.63K | 1,048 |
| CFO | Klompas Neil A | Mar 10, 2021 | Sell | $49.81K | 1,425 |
| Chief People Officer | O'Driscoll Kathryn | Mar 10, 2021 | Sell | $19.85K | 568 |
| CFO | Klompas Neil A | Dec 9, 2020 | Sell | $1.33M | 25,000 |
| CEO | Tehrani Ali | Dec 7, 2020 | Sell | $47.74K | 850 |
| Chief Medical Officer | HAUSMAN DIANA | Dec 4, 2020 | Sell | $332.48K | 6,032 |
| Chief Medical Officer | HAUSMAN DIANA | Dec 2, 2020 | Sell | $38.56K | 701 |
| Chief Medical Officer | HAUSMAN DIANA | Dec 1, 2020 | Sell | $1.01M | 18,267 |
| CEO | Tehrani Ali | Nov 2, 2020 | Sell | $136.62K | 3,500 |
| Chief Medical Officer | HAUSMAN DIANA | Sep 14, 2020 | Sell | $1.8M | 40,000 |
| CEO | Tehrani Ali | Apr 3, 2020 | Buy | $16.53K | 495 |
| CEO | Tehrani Ali | Apr 3, 2020 | Buy | $2.67K | 80 |
| Director | Cox Troy | Jan 27, 2020 | Buy | $348.75K | 7,500 |
| CFO | Klompas Neil A | May 6, 2019 | Sell | $128.85K | 6,704 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.
